Dr. Basil K. Williams, MD

Dr. Williams practices at Sylvester Comprehensive Cancer Center in Miami, Florida, part of University of Miami.

Dr. Williams' NPI, 1942578356, was assigned on December 13, 2011. Dr. Williams graduated from Chicago Medical School at Rosalind Franklin University of Medicine and Science in 2011. Dr. Williams holds Florida license ME158524.

Dr. Williams' primary practice is Sylvester Comprehensive Cancer Center, at 1475 Nw 12th Ave, Miami, FL 33136.

Dr. Williams' primary practice is Sylvester Comprehensive Cancer Center in Miami, Florida, part of University of Miami. Dr. Williams is also affiliated with Jackson Memorial Hospital. The medical group on file is University of Miami Health System. Dmand AI also links Dr. Williams to 3 more medical groups and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Williams practices, 3 sites in all. Vendor and product names are available with a free account.

Ophthalmology is Dr. Williams' primary specialty in the NPI Registry, under taxonomy code 207W00000X. Dr. Williams is board certified in ophthalmology by the American Board of Ophthalmology. Dmand AI has Dr. Williams' licenses on file in 4 states: Florida, Ohio, Pennsylvania and Illinois.

Dmand AI lists age-related macular degeneration, cataract surgery with lens implant, dry eye, laser destruction of retinal or choroid lesions, retinal detachment, retinal occlusion, surgical retina and vitreous procedures and vision problems among the conditions Dr. Williams treats.

CMS data shows 1,175 Medicare services from Dr. Williams across 10 procedure codes in 2024, for 299 Medicare patients. Medicare paid $56,561 for them.

CMS counts 299 Medicare patients who saw Dr. Williams in 2024. The largest group is 65 to 74, with 127 patients. 75% of them have high cholesterol, and 74% have high blood pressure. 15% are also on Medicaid. Their average risk score is 1.42, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Williams' median patient age at 71, with 53% women.

In 2024, Dr. Williams wrote 301 Medicare Part D claims for 111 patients. 72% of them were for generic drugs. CMS names the drug for 240 of them, across 5 drugs with 11 or more claims each, at $4,740 in total drug cost. In 2023, CMS named 112 claims across 4 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 88 out of 100 for Dr. Williams for performance year 2024, reported as part of a group. Dr. Williams accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 89 papers to Dr. Williams, published from 2010 to 2025. 2024 was the busiest year, with 14. The most frequent topics are Tomography, Optical Coherence, Visual Acuity and Fluorescein Angiography. Dr. Williams has published most often in Ophthalmol Retina. Dr. Williams' most frequent co-authors are Jayanth Srinivasan-Kasi Sridhar, MD, Jared Jamieson Ebert, MD and Daniel Gologorsky, MBA, MD.

CMS Open Payments shows 180 general payments to Dr. Williams from 26 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 80% of the total. Regeneron Pharmaceuticals, Inc. paid the most, $28,485. It also lists 3 research payments totaling $7,885 from 2024 to 2025, naming 1 clinical trial.

Dr. Williams graduated from Chicago Medical School at Rosalind Franklin University of Medicine and Science in 2011.

Dr. Williams is in network with 20 carriers, including Aetna, Elevance and Excellus BlueCross BlueShield. Medicare plans come from the most carriers, 12. Check the plan with the practice before a visit.